Cita APA

Hart, D. E., Gallagher, J. C., Puzniak, L. A., Hirsch, E. B., & Hirsch, E. B. (2019). 2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients with Multidrug-Resistant (MDR) Pseudomonas aeruginosa (PA) Infections. Open Forum Infect Dis.

Citación estilo Chicago

Hart, Delaney E., Jason C. Gallagher, Laura A. Puzniak, Elizabeth B. Hirsch, and Elizabeth B. Hirsch. "2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients With Multidrug-Resistant (MDR) Pseudomonas Aeruginosa (PA) Infections." Open Forum Infect Dis 2019.

Cita MLA

Hart, Delaney E., et al. "2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients With Multidrug-Resistant (MDR) Pseudomonas Aeruginosa (PA) Infections." Open Forum Infect Dis 2019.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.